Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 11.08 billion as of March 6, 2026. Its market cap has decreased by -37.41% in one year.

Market Cap

11.08B

Enterprise Value

11.32B

Revenue

3.85B

Ranking

n/a

PE Ratio

27.77

Stock Price

1,098.00

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 11.08B, an increase of 1,110.05%. That is a compound annual growth rate of 34.71%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	11.08B	-29.12%
Dec 31, 2025	15.64B	-19.04%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	Pro	Pro
Dec 27, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jagsonpal Pharmaceuticals	11.41B
Sakar Healthcare	11.60B
Ind-Swift Laboratories	11.90B
Sigachi Industries	7.40B
Windlas Biotech	15.83B
Indoco Remedies	18.23B
Solara Active Pharma Sciences	22.24B
Orchid Pharma	27.32B

Market Cap Rankings